Hypoparathyroidism.
John P Bilezikian
https://pubmed.ncbi.nlm.nih.gov/32322899Actively Recruiting
Age: 18Years +
All Genders
ID05585593
Registry and Biobank for Patients With Hypoparathyroidism Wuerzburg
Led by University of Wuerzburg · Updated on 2022-11-08
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying chronic hypoparathyroidism, a condition where long-term treatment does not fully restore calcium balance, leading to more health problems, emergency events, and reduced quality of life. This observational trial aims to better understand the general health issues, calcium level events, and daily life impact for patients with chronic hypoparathyroidism or pseudohypoparathyroidism. Participants will undergo standardized interviews, blood tests, and medical examinations including echocardiography and kidney ultrasound. The study compares patients' data to matched controls over a long period, documenting health status and complications related to calcium imbalances. During the study, participants will provide health information through interviews and undergo various medical assessments to monitor comorbidities, calcium-related events, and overall subjective health. Researchers will track these outcomes for up to 15 years, analyzing data while ensuring privacy through pseudonymization. The study supports long-term monitoring of patient health and quality of life.
CONDITIONS
Brief Title
Registry for Hypoparathyroidism Wuerzburg
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Age of 18 years or older
- Diagnosis of chronic hypoparathyroidism or chronic pseudohypoparathyroidism for more than 12 months under established therapy
- Ability to provide written informed consent
You will not qualify if you...
- Age under 18 years
- Lack of detailed medical documentation of hypo- or pseudohypoparathyroidism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Long-term Monitoring
Duration - Up to 15 years
Participants with chronic hypoparathyroidism are observed over an extended period to evaluate comorbidities, mortality, calcium events, and quality of life through interviews, blood sampling, and additional examinations.
Trial Site Locations
Total: 1 location
1
Dept. of Endocrinology and Diabetology, Dept. of Medicine I, University Hospital Wuerzburg
Würzburg, Bavaria, Germany, 97080
Actively Recruiting
Loading map...
Research Team
S
Stefanie Hahner, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada.
Aliya A Khan, Hajar AbuAlrob, Zubin Punthakee...
https://pubmed.ncbi.nlm.nih.gov/33655415Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study.
Line Underbjerg, Tanja Sikjaer, Leif Mosekilde...
https://pubmed.ncbi.nlm.nih.gov/23661265Cardiovascular status in chronic hypoparathyroidism: a systematic cross-sectional assessment in 168 patients.
Carmina Teresa Fuss, Karen Gronemeyer, Franca Hermes...
https://pubmed.ncbi.nlm.nih.gov/40172208Renal complications in chronic hypoparathyroidism - a systematic cross-sectional assessment.
Karen Gronemeyer, Carmina Teresa Fuss, Franca Hermes...
https://pubmed.ncbi.nlm.nih.gov/38027217